Response to first vaccination against SARS-CoV-2 in patients with multiple myeloma
Gespeichert in:
| Veröffentlicht in: | The Lancet. Haematology 2021-06, Vol.8 (6), p.e389-e392 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | e392 |
|---|---|
| container_issue | 6 |
| container_start_page | e389 |
| container_title | The Lancet. Haematology |
| container_volume | 8 |
| creator | Bird, Sarah Panopoulou, Aikaterini Shea, Robyn L Tsui, Micky Saso, Radovan Sud, Amit West, Sharon Smith, Katy Barwood, John Kaczmarek, Ewa Panlaqui, Carmela Kaiser, Martin Stern, Simon Pawlyn, Charlotte Boyd, Kevin |
| description | |
| doi_str_mv | 10.1016/S2352-3026(21)00110-1 |
| format | Article |
| fullrecord | <record><control><sourceid>elsevier_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8055205</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S2352302621001101</els_id><sourcerecordid>S2352302621001101</sourcerecordid><originalsourceid>FETCH-LOGICAL-c467t-7729bb348f20025489ed419e6f30513a7c84b7cce3e4db0754850d02b028feab3</originalsourceid><addsrcrecordid>eNqFkM1OwzAQhC0EolXhEUA-wiGwtuMkvYCqij8JCakFrpbjbFqjJI7itIi3x1CoyonTrnZnZu2PkBMGFwxYcjnnQvJIAE_OODsHYAwitkeG2_H-Tj8gx96_QVCJNJHJ-JAMhMiylEs5JLMZ-tY1HmnvaGk739O1NsY2ureuoXqhbRNm88lsHk3da8SpbWgbltj0nr7bfknrVdXbtkJaf2Dlan1EDkpdeTz-qSPycnvzPL2PHp_uHqaTx8jESdpHacrHeS7irOQAXMbZGIuYjTEpBUgmdGqyOE-NQYFxkUMaFBIK4DnwrESdixG52uS2q7zGwoQXdbpSbWdr3X0op636u2nsUi3cWmUgJQcZAuQmwHTO-w7LrZeB-uKsvjmrL4iKM_XNWbHgO909vHX9Ug2C640Aw_fXFjvlTQBmsLAdml4Vzv5z4hNHJI2B</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Response to first vaccination against SARS-CoV-2 in patients with multiple myeloma</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Bird, Sarah ; Panopoulou, Aikaterini ; Shea, Robyn L ; Tsui, Micky ; Saso, Radovan ; Sud, Amit ; West, Sharon ; Smith, Katy ; Barwood, John ; Kaczmarek, Ewa ; Panlaqui, Carmela ; Kaiser, Martin ; Stern, Simon ; Pawlyn, Charlotte ; Boyd, Kevin</creator><creatorcontrib>Bird, Sarah ; Panopoulou, Aikaterini ; Shea, Robyn L ; Tsui, Micky ; Saso, Radovan ; Sud, Amit ; West, Sharon ; Smith, Katy ; Barwood, John ; Kaczmarek, Ewa ; Panlaqui, Carmela ; Kaiser, Martin ; Stern, Simon ; Pawlyn, Charlotte ; Boyd, Kevin</creatorcontrib><identifier>ISSN: 2352-3026</identifier><identifier>EISSN: 2352-3026</identifier><identifier>DOI: 10.1016/S2352-3026(21)00110-1</identifier><identifier>PMID: 33887255</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Aged ; Aged, 80 and over ; Antibodies, Viral - blood ; Comment ; COVID-19 - blood ; COVID-19 - etiology ; COVID-19 - prevention & control ; COVID-19 Vaccines - adverse effects ; COVID-19 Vaccines - therapeutic use ; Humans ; Immunoglobulin G - blood ; Male ; Middle Aged ; Multiple Myeloma - blood ; Multiple Myeloma - complications ; Retrospective Studies ; Risk Factors ; SARS-CoV-2 - isolation & purification ; Vaccination</subject><ispartof>The Lancet. Haematology, 2021-06, Vol.8 (6), p.e389-e392</ispartof><rights>2021 Elsevier Ltd</rights><rights>2021 Elsevier Ltd. All rights reserved. 2021 Elsevier Ltd</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c467t-7729bb348f20025489ed419e6f30513a7c84b7cce3e4db0754850d02b028feab3</citedby><cites>FETCH-LOGICAL-c467t-7729bb348f20025489ed419e6f30513a7c84b7cce3e4db0754850d02b028feab3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27923,27924</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33887255$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bird, Sarah</creatorcontrib><creatorcontrib>Panopoulou, Aikaterini</creatorcontrib><creatorcontrib>Shea, Robyn L</creatorcontrib><creatorcontrib>Tsui, Micky</creatorcontrib><creatorcontrib>Saso, Radovan</creatorcontrib><creatorcontrib>Sud, Amit</creatorcontrib><creatorcontrib>West, Sharon</creatorcontrib><creatorcontrib>Smith, Katy</creatorcontrib><creatorcontrib>Barwood, John</creatorcontrib><creatorcontrib>Kaczmarek, Ewa</creatorcontrib><creatorcontrib>Panlaqui, Carmela</creatorcontrib><creatorcontrib>Kaiser, Martin</creatorcontrib><creatorcontrib>Stern, Simon</creatorcontrib><creatorcontrib>Pawlyn, Charlotte</creatorcontrib><creatorcontrib>Boyd, Kevin</creatorcontrib><title>Response to first vaccination against SARS-CoV-2 in patients with multiple myeloma</title><title>The Lancet. Haematology</title><addtitle>Lancet Haematol</addtitle><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Antibodies, Viral - blood</subject><subject>Comment</subject><subject>COVID-19 - blood</subject><subject>COVID-19 - etiology</subject><subject>COVID-19 - prevention & control</subject><subject>COVID-19 Vaccines - adverse effects</subject><subject>COVID-19 Vaccines - therapeutic use</subject><subject>Humans</subject><subject>Immunoglobulin G - blood</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Multiple Myeloma - blood</subject><subject>Multiple Myeloma - complications</subject><subject>Retrospective Studies</subject><subject>Risk Factors</subject><subject>SARS-CoV-2 - isolation & purification</subject><subject>Vaccination</subject><issn>2352-3026</issn><issn>2352-3026</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkM1OwzAQhC0EolXhEUA-wiGwtuMkvYCqij8JCakFrpbjbFqjJI7itIi3x1CoyonTrnZnZu2PkBMGFwxYcjnnQvJIAE_OODsHYAwitkeG2_H-Tj8gx96_QVCJNJHJ-JAMhMiylEs5JLMZ-tY1HmnvaGk739O1NsY2ureuoXqhbRNm88lsHk3da8SpbWgbltj0nr7bfknrVdXbtkJaf2Dlan1EDkpdeTz-qSPycnvzPL2PHp_uHqaTx8jESdpHacrHeS7irOQAXMbZGIuYjTEpBUgmdGqyOE-NQYFxkUMaFBIK4DnwrESdixG52uS2q7zGwoQXdbpSbWdr3X0op636u2nsUi3cWmUgJQcZAuQmwHTO-w7LrZeB-uKsvjmrL4iKM_XNWbHgO909vHX9Ug2C640Aw_fXFjvlTQBmsLAdml4Vzv5z4hNHJI2B</recordid><startdate>20210601</startdate><enddate>20210601</enddate><creator>Bird, Sarah</creator><creator>Panopoulou, Aikaterini</creator><creator>Shea, Robyn L</creator><creator>Tsui, Micky</creator><creator>Saso, Radovan</creator><creator>Sud, Amit</creator><creator>West, Sharon</creator><creator>Smith, Katy</creator><creator>Barwood, John</creator><creator>Kaczmarek, Ewa</creator><creator>Panlaqui, Carmela</creator><creator>Kaiser, Martin</creator><creator>Stern, Simon</creator><creator>Pawlyn, Charlotte</creator><creator>Boyd, Kevin</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope></search><sort><creationdate>20210601</creationdate><title>Response to first vaccination against SARS-CoV-2 in patients with multiple myeloma</title><author>Bird, Sarah ; Panopoulou, Aikaterini ; Shea, Robyn L ; Tsui, Micky ; Saso, Radovan ; Sud, Amit ; West, Sharon ; Smith, Katy ; Barwood, John ; Kaczmarek, Ewa ; Panlaqui, Carmela ; Kaiser, Martin ; Stern, Simon ; Pawlyn, Charlotte ; Boyd, Kevin</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c467t-7729bb348f20025489ed419e6f30513a7c84b7cce3e4db0754850d02b028feab3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Antibodies, Viral - blood</topic><topic>Comment</topic><topic>COVID-19 - blood</topic><topic>COVID-19 - etiology</topic><topic>COVID-19 - prevention & control</topic><topic>COVID-19 Vaccines - adverse effects</topic><topic>COVID-19 Vaccines - therapeutic use</topic><topic>Humans</topic><topic>Immunoglobulin G - blood</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Multiple Myeloma - blood</topic><topic>Multiple Myeloma - complications</topic><topic>Retrospective Studies</topic><topic>Risk Factors</topic><topic>SARS-CoV-2 - isolation & purification</topic><topic>Vaccination</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bird, Sarah</creatorcontrib><creatorcontrib>Panopoulou, Aikaterini</creatorcontrib><creatorcontrib>Shea, Robyn L</creatorcontrib><creatorcontrib>Tsui, Micky</creatorcontrib><creatorcontrib>Saso, Radovan</creatorcontrib><creatorcontrib>Sud, Amit</creatorcontrib><creatorcontrib>West, Sharon</creatorcontrib><creatorcontrib>Smith, Katy</creatorcontrib><creatorcontrib>Barwood, John</creatorcontrib><creatorcontrib>Kaczmarek, Ewa</creatorcontrib><creatorcontrib>Panlaqui, Carmela</creatorcontrib><creatorcontrib>Kaiser, Martin</creatorcontrib><creatorcontrib>Stern, Simon</creatorcontrib><creatorcontrib>Pawlyn, Charlotte</creatorcontrib><creatorcontrib>Boyd, Kevin</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>The Lancet. Haematology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bird, Sarah</au><au>Panopoulou, Aikaterini</au><au>Shea, Robyn L</au><au>Tsui, Micky</au><au>Saso, Radovan</au><au>Sud, Amit</au><au>West, Sharon</au><au>Smith, Katy</au><au>Barwood, John</au><au>Kaczmarek, Ewa</au><au>Panlaqui, Carmela</au><au>Kaiser, Martin</au><au>Stern, Simon</au><au>Pawlyn, Charlotte</au><au>Boyd, Kevin</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Response to first vaccination against SARS-CoV-2 in patients with multiple myeloma</atitle><jtitle>The Lancet. Haematology</jtitle><addtitle>Lancet Haematol</addtitle><date>2021-06-01</date><risdate>2021</risdate><volume>8</volume><issue>6</issue><spage>e389</spage><epage>e392</epage><pages>e389-e392</pages><issn>2352-3026</issn><eissn>2352-3026</eissn><cop>England</cop><pub>Elsevier Ltd</pub><pmid>33887255</pmid><doi>10.1016/S2352-3026(21)00110-1</doi><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 2352-3026 |
| ispartof | The Lancet. Haematology, 2021-06, Vol.8 (6), p.e389-e392 |
| issn | 2352-3026 2352-3026 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8055205 |
| source | MEDLINE; Alma/SFX Local Collection |
| subjects | Aged Aged, 80 and over Antibodies, Viral - blood Comment COVID-19 - blood COVID-19 - etiology COVID-19 - prevention & control COVID-19 Vaccines - adverse effects COVID-19 Vaccines - therapeutic use Humans Immunoglobulin G - blood Male Middle Aged Multiple Myeloma - blood Multiple Myeloma - complications Retrospective Studies Risk Factors SARS-CoV-2 - isolation & purification Vaccination |
| title | Response to first vaccination against SARS-CoV-2 in patients with multiple myeloma |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-12T11%3A53%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-elsevier_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Response%20to%20first%20vaccination%20against%20SARS-CoV-2%20in%20patients%20with%20multiple%20myeloma&rft.jtitle=The%20Lancet.%20Haematology&rft.au=Bird,%20Sarah&rft.date=2021-06-01&rft.volume=8&rft.issue=6&rft.spage=e389&rft.epage=e392&rft.pages=e389-e392&rft.issn=2352-3026&rft.eissn=2352-3026&rft_id=info:doi/10.1016/S2352-3026(21)00110-1&rft_dat=%3Celsevier_pubme%3ES2352302621001101%3C/elsevier_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/33887255&rft_els_id=S2352302621001101&rfr_iscdi=true |